Inventor · disambiguated record
Mariano A. Garcia-Blanco
Also filed as: GARCIA-BLANCO MARIANO · GARCIA-BLANCO MARIANO A
18 granted patents·22 pending applications·274 citations·filing 1998–2023
93Inventor score
Top patents by PatentIndex Score
40 records- 0192US6083702AMethods and compositions for use in spliceosome mediated RNA trans-splicingINTRONN HOLDINGS LLC·Filed 1998·Granted Jul 4, 2000·170 cites·37 claims
- 0290US11118186B2Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancerUNIV TEXAS·Filed 2020·Granted Sep 14, 2021·2 cites·17 claims
- 0389US10161939B2Method of isolating circulating tumor cellsUNIV DUKE·Filed 2013·Granted Dec 25, 2018·10 cites·11 claims
- 0489US9845481B2Synthetic regulation of gene expressionUNIV DUKE·Filed 2016·Granted Dec 19, 2017·6 cites·22 claims
- 0585US12359204B2Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancerUNIV TEXAS·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0685US12247206B2Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancerUNIV TEXAS·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0783US10961581B2Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)UNIV TEXAS·Filed 2018·Granted Mar 30, 2021·4 cites·2 claims
- 0881US7968334B2Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicingVIRXSYS CORP·Filed 2005·Granted Jun 28, 2011·4 cites·25 claims
- 0981US6280978B1Methods and compositions for use in spliceosome mediated RNA trans-splicingINTRONN HOLDINGS LLC·Filed 1998·Granted Aug 28, 2001·55 cites·32 claims
- 1080US11567081B2Method of isolating circulating tumor cellsUNIV DUKE·Filed 2018·Granted Jan 31, 2023·1 cites·19 claims
- 1180US9284575B2Synthetic regulation of gene expressionUNIV DUKE·Filed 2013·Granted Mar 15, 2016·3 cites·15 claims
- 1277US8158344B2Methods and compositions for correlating genetic markers with multiple sclerosisHAINES JONATHAN L·Filed 2008·Granted Apr 17, 2012·11 cites·6 claims
- 1377US8053232B2Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicingVIRXSYS CORP·Filed 2005·Granted Nov 8, 2011·4 cites·24 claims
- 1476US7871795B2Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteinsVIRXSYS CORP·Filed 2005·Granted Jan 18, 2011·2 cites·10 claims
- 1575US11807853B2Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancerUNIV TEXAS·Filed 2021·Granted Nov 7, 2023·0 cites·21 claims
- 1675US2023184776A1Method of isolating circulating tumor cellsUNIV DUKE·Filed 2022·Application pending·0 cites
- 1774US7879321B2Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide productionVIRXSYS CORP·Filed 2005·Granted Feb 1, 2011·2 cites·16 claims
- 1862US12203138B2Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)UNIV TEXAS·Filed 2021·Granted Jan 21, 2025·0 cites·17 claims
- 1962US2025250346A1Anti-soluble interleukin-7 receptor antibody therapy to treat autoimmune diseasesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2058US2025127870A1mRNA Vaccines Against HantavirusUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2158US2025368999A1Soluble interleukin-7 receptor (sil7r) modulating therapy to treat cancerGARCIA BLANCO MARIANO A·Filed 2021·Application pending·0 cites
- 2251US2004014107A1RNP immunoprecipitation assayFiled 2003·Application pending·0 cites
- 2350US2006154257A1Screening method for identification of efficient pre-trans-splicing moleculesMITCHELL LLOYD G·Filed 2004·Application pending·0 cites
- 2450US2006094110A1Use of spliceosome mediated RNA trans-splicing for immunotherapyMCGARRITY GERARD J·Filed 2005·Application pending·0 cites
- 2549US2003027250A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2001·Application pending·0 cites
- 2649US2006246422A1Methods and compositions for use in spliceosome mediated RNA trans-splicingMITCHELL LLOYD G·Filed 2005·Application pending·0 cites
- 2747US8883753B2Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicingPUTTARAJU MADAIAH·Filed 2011·Granted Nov 11, 2014·0 cites·9 claims
- 2844US2006134658A1Use of RNA trans-splicing for generation of interfering RNA moleculesGARCIA-BLANCO MARIANO A·Filed 2005·Application pending·0 cites
- 2944US2003153054A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2002·Application pending·0 cites
- 3043US2002193580A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2002·Application pending·0 cites
- 3143US2006088938A1Methods and compositions for use in spliceosome mediated RNA trans-splicing in plantsMITCHELL LLOYD G·Filed 2001·Application pending·0 cites
- 3242US2011244519A1Use of rna trans-splicing for antibody gene transfer and antibody polypeptide productionVIRXSYS CORP·Filed 2011·Application pending·0 cites
- 3338US2002115207A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2001·Application pending·0 cites
- 3437US2018231560A1Compositions and Methods for the Capture and Characterization of Circulating Tumor CellsUNIV DUKE·Filed 2015·Application pending·0 cites
- 3537US2013209493A1Biomakers for circulating tumor cellsGARCIA-BLANCO MARIANO·Filed 2010·Application pending·0 cites
- 3637US2003148937A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2001·Application pending·0 cites
- 3736US2004214263A1Spliceosome mediated RNA trans-splicingFiled 2002·Application pending·0 cites
- 3835US2003077754A1Methods and compositions for use in spliceosome mediated RNA trans-splicingFiled 2001·Application pending·0 cites
- 3934US2006177933A1Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicingPUTTARAJU MADAIAH·Filed 2005·Application pending·0 cites
- 4015US2002009755A1Alternative splicing of fibroblast growth factor receptor 2 mrna in prostate cancerFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mariano A. Garcia-Blanco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →